Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care

Stock price data as of 05/17/2019

Closing price: 229.28

Support price level:	N/A
Resistance price level:	$244.38
Relative strength index (14-day RSI)	49.8
Beta	1.33

BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 36.2%.
Volatility is forecast to fall over the next month.
BIIB is below its 200-day moving average - additional caution warranted in long positions.
Price broke below prior support level - a short-term bearish signal.

Low	High	Price as % of Range
$216.71	$383.83	9.9%

200 day	50 day	20 day	10 day
$308.18	$246.69	$229.50	$229.63

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
37.4%	38.1%	36.2%	37.2%

There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than: